BROKERAGE RADAR:

BoFA ML: SUN PHARMA : Potential upside for stock could be  over 40% if Halol does not escalate
BoFA ML: SUN PHARMA : Fair value works out to be ₹757 in  case of import alert
BoFA ML: SUN PHARMA : Street is factoring in worst outcome at the Halol plant
BoFA ML: SUN PHARMA : Recent correction offers particularly  attractive entry point
BoFA ML: SUN PHARMA : Maintains Buy, target of ₹1,070

CS ON KAVERI SEEDS : Valuation attractive but lack of  near-term triggers is a concern
CS ON KAVERI SEEDS : Cut earnings by 25-35% on current  weakness, gradual recovery in cotton vol
CS ON KAVERI SEEDS : Weakness in cotton likely to continue in FY17
CS ON KAVERI SEEDS : Inventory write-off due to non-cotton  returns hurts Q2 numbers
CS ON KAVERI SEEDS : Maintains Outperform, cuts target to ₹650 from ₹800

JPM ON APOLLO TYRES : Company's new plant in Hungary will be  commissioned in early 2017
JPM ON APOLLO TYRES : Strategic initiative by company to  expand last mile distribution in Europe
JPM ON APOLLO TYRES : Company plans to increase sales of Apollo and Vredestin branded tyres
JPM ON APOLLO TYRES : Acquisition of tyre retail outfit is to  enhance distribution reach

JPMORGAN ON ICICI BK : We think this could pave the way for a  possible future listing for ins venture
JPMORGAN ON ICICI BK : Positive impact on ICICI's capital base would be a marginal at 3%
JPMORGAN ON ICICI BK : There is no capital infusion into  insurance arm as it is a direct sale
JPMORGAN ON ICICI BK : See deal as an incremental positive for  its price discovery impact
JPMORGAN ON ICICI BK : Deal values ICICI Prudential Life at ₹32,500 cr, in line with our valuation
JPMORGAN ON ICICI BK : Positive impact on ICICI's capital base would be marginal at 3%